Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9800)
All Articles published online
|
Publishing Process of This Article
|
Aug 28, 2013 (publication date) through Jul 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Greene CM, Varley RB, Lawless MW. MicroRNAs and liver cancer associated with iron overload: Therapeutic targets unravelled. World J Gastroenterol 2013; 19(32): 5212-5226 [PMID: 23983424 DOI: 10.3748/wjg.v19.i32.5212] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i32/5212.htm |
| Number | Citing Articles |
| 1 |
Zheng Lou, Yong‑Qiang Gong, Xing Zhou, Guo‑Huang Hu. Low expression of miR‑199 in hepatocellular carcinoma contributes to tumor cell hyper‑proliferation by negatively suppressing XBP1. Oncology Letters 2018; doi: 10.3892/ol.2018.9476
|
| 2 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3029 doi: 10.1007/978-3-319-26956-6_168
|
| 3 |
Guy Rostoker, Nosratola D. Vaziri. Impact of iatrogenic iron overload on the course of hepatitis C in the dialysis population: A plea for caution. Hemodialysis International 2017; 21(S1) doi: 10.1111/hdi.12557
|
| 4 |
Weijia Wang, Behishta Hashimi, Ping Wang. Targeting ferroptosis: the role of non-coding RNAs in hepatocellular carcinoma progression and therapy. Naunyn-Schmiedeberg's Archives of Pharmacology 2025; 398(6): 6335 doi: 10.1007/s00210-025-03791-y
|
| 5 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_168-1
|
| 6 |
Gayatri Gouda, Manoj Kumar Gupta, Ravindra Donde, Lambodar Behera, Ramakrishna Vadde. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; : 83 doi: 10.1016/B978-0-323-98807-0.00003-X
|
| 7 |
Shokufeh Razi, Javad Yaghmoorian Khojini, Hamid Norioun, Mohammad Javad Hayati, Nasim Naseri, Amir Tajbaksh, Seyed Mohammad Gheibihayat. MicroRNA-mediated regulation of Ferroptosis: Implications for disease pathogenesis and therapeutic interventions. Cellular Signalling 2025; 125: 111503 doi: 10.1016/j.cellsig.2024.111503
|
| 8 |
Michael C. Kew. Hepatic Iron Overload and Hepatocellular Carcinoma. Liver Cancer 2014; 3(1): 31 doi: 10.1159/000343856
|
| 9 |
Hongyu Zhang, Hongxia Liang, Shuhuan Wu, Yingying Zhang, Zujiang Yu. MicroRNA-638 induces apoptosis and autophagy in human liver cancer cells by targeting enhancer of zeste homolog 2 (EZH2). Environmental Toxicology and Pharmacology 2021; 82: 103559 doi: 10.1016/j.etap.2020.103559
|
| 10 |
Chan Shan, Yan Liang, Kun Wang, Peifeng Li. Noncoding RNAs in cancer ferroptosis: From biology to clinical opportunity. Biomedicine & Pharmacotherapy 2023; 165: 115053 doi: 10.1016/j.biopha.2023.115053
|
| 11 |
Tong-Jiang Xu, Peng Qiu, Yu-Bao Zhang, Sheng-Yuan Yu, Guang-Ming Xu, Wei Yang. MiR-148a inhibits the proliferation and migration of glioblastoma by targeting ITGA9. Human Cell 2019; 32(4): 548 doi: 10.1007/s13577-019-00279-9
|
| 12 |
Aakash Desai, Sonia Sandhu, Jin-Ping Lai, Dalbir Singh Sandhu. Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review. World Journal of Hepatology 2019; 11(1): 1-18 doi: 10.4254/wjh.v11.i1.1
|
| 13 |
Ling Yin, Geoffrey D. Keeler, Yuanhui Zhang, Brad E. Hoffman, Chen Ling, Keyun Qing, Arun Srivastava. AAV3-miRNA vectors for growth suppression of human hepatocellular carcinoma cells in vitro and human liver tumors in a murine xenograft model in vivo. Gene Therapy 2021; 28(7-8): 422 doi: 10.1038/s41434-020-0140-1
|
| 14 |
Tomer Adar, Yaron Ilan, Deborah Elstein, Ari Zimran. Liver involvement in Gaucher disease – Review and clinical approach. Blood Cells, Molecules, and Diseases 2018; 68: 66 doi: 10.1016/j.bcmd.2016.10.001
|
| 15 |
Xiao-Ying Chen, Yao-Xing Dou, Dan-Dan Luo, Zhen-Biao Zhang, Cai-Lan Li, Hui-Fang Zeng, Zi-Ren Su, Jian-Hui Xie, Xiao-Ping Lai, Yu-Cui Li. β-Patchoulene from patchouli oil protects against LPS-induced acute lung injury via suppressing NF-κB and activating Nrf2 pathways. International Immunopharmacology 2017; 50: 270 doi: 10.1016/j.intimp.2017.07.001
|
| 16 |
Pierre Lelièvre, Lucie Sancey, Jean-Luc Coll, Aurélien Deniaud, Benoit Busser. Iron Dysregulation in Human Cancer: Altered Metabolism, Biomarkers for Diagnosis, Prognosis, Monitoring and Rationale for Therapy. Cancers 2020; 12(12): 3524 doi: 10.3390/cancers12123524
|
| 17 |
Huiqing Wang, Xiaoyu Shi, Shanbin Wu. miR-550a-3/NFIC plays a driving role in esophageal squamous cell cancer cells proliferation and metastasis partly through EMT process. Molecular and Cellular Biochemistry 2020; 472(1-2): 115 doi: 10.1007/s11010-020-03790-y
|
| 18 |
Yichao Zhao, Chaoqian Zhu, Qing Chang, Peng Peng, Jie Yang, Chunmei Liu, Yang Liu, Xiaonan Chen, Yuanguang Liu, Ran Cheng, Yijie Wu, Xiaotang Wu, Liang Hu, Jun Yin, Klaus Roemer. MiR-424-5p regulates cell cycle and inhibits proliferation of hepatocellular carcinoma cells by targeting E2F7. PLOS ONE 2020; 15(11): e0242179 doi: 10.1371/journal.pone.0242179
|
| 19 |
Qinghua Peng, Xiaoning Zhu, Yuanyuan Jiang, Mengyun Peng, Ding Zheng, Xiaodong Wang, Yoke Kqueen Cheah, Jing Wang. Evaluating the roles of microRNAs associated with nonalcoholic fatty liver disease in hepatocellular carcinoma tumorigenesis: a systematic review and network analysis. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1462513
|
| 20 |
Abolfazl Akbari, Hassan Mehrad Majd, Reyhane Rahnama, Javad Heshmati, Mojgan Morvaridzadeh, Shahram Agah, Seyed Mohammad Amini, Mohsen Masoodi. Cross-talk between oxidative stress signaling and microRNA regulatory systems in carcinogenesis: Focused on gastrointestinal cancers. Biomedicine & Pharmacotherapy 2020; 131: 110729 doi: 10.1016/j.biopha.2020.110729
|
| 21 |
Jing Chen, Kai Zhang, Yuejuan Xu, Yanping Gao, Chen Li, Rui Wang, Longbang Chen. The role of microRNA-26a in human cancer progression and clinical application. Tumor Biology 2016; 37(6): 7095 doi: 10.1007/s13277-016-5017-y
|
| 22 |
Nashwa El-Khazragy, Safa Matbouly, Demiana H. Hanna, Nievin Ahmed Mahran, Sally Abdallah Mostafa, Bassam A. Abdelrehim, Yasmeen K. Farouk, Soha Abuelela. Circulating miRNAs and tissue iron overload in transfusion-dependent β-thalassemia major: novel predictors and follow-up guide. Annals of Hematology 2021; 100(12): 2909 doi: 10.1007/s00277-021-04639-0
|
| 23 |
Gayatri Gouda, Manoj Kumar Gupta, Ravindra Donde, Lambodar Behera, Ramakrishna Vadde. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 109 doi: 10.1016/B978-0-323-98806-3.00007-6
|
| 24 |
Xuefei Zhang, Lingling Wang, Haixia Li, Lei Zhang, Xiulan Zheng, Wen Cheng. Crosstalk between noncoding RNAs and ferroptosis: new dawn for overcoming cancer progression. Cell Death & Disease 2020; 11(7) doi: 10.1038/s41419-020-02772-8
|
| 25 |
Linqiang Gong, Linlin Wu, Shiyuan Zhao, Shuai Xiao, Xue Chu, Yazhou Zhang, Fengfeng Li, Shuhui Li, Hui Yang, Pei Jiang. Epigenetic regulation of ferroptosis in gastrointestinal cancers (Review). International Journal of Molecular Medicine 2025; 55(6): 1 doi: 10.3892/ijmm.2025.5534
|
| 26 |
Yukio Osaki, Hiroki Nishikawa. Treatment for hepatocellular carcinoma in Japan over the last three decades: Our experience and published work review. Hepatology Research 2015; 45(1): 59 doi: 10.1111/hepr.12378
|
| 27 |
Jun Zhao, Matthew W. Lawless. MicroRNAs and Other Non-Coding RNAs in Inflammation. 2015; : 219 doi: 10.1007/978-3-319-13689-9_12
|
| 28 |
Siqi Zhao, Wubin Zheng, Chao Yu, Gaoxin Xu, Xinyi Zhang, Chao Pan, Yongheng Feng, Kunxing Yang, Jin Zhou, Yong Ma. The Role of Ferroptosis in the Treatment and Drug Resistance of Hepatocellular Carcinoma. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.845232
|
| 29 |
Yu Liu, Guangyan Li, Fayu Lu, Ziwei Guo, Shuang Cai, Taoguang Huo. Excess iron intake induced liver injury: The role of gut-liver axis and therapeutic potential. Biomedicine & Pharmacotherapy 2023; 168: 115728 doi: 10.1016/j.biopha.2023.115728
|
| 30 |
Shane O’Grady, Matthew W. Lawless. Epigenetic Cancer Therapy. 2015; : 269 doi: 10.1016/B978-0-12-800206-3.00012-4
|
| 31 |
Fangfang Guo, Xiaotang Yang, Chengxiang Hu, Wannan Li, Weiwei Han. Network Pharmacology Combined with Machine Learning to Reveal the Action Mechanism of Licochalcone Intervention in Liver Cancer. International Journal of Molecular Sciences 2023; 24(21): 15935 doi: 10.3390/ijms242115935
|
| 32 |
Wujun Chen, Xiaolin Wu, Jianxia Hu, Xiaolei Liu, Zhu Guo, Jianfeng Wu, Yingchun Shao, Minglu Hao, Shuangshuang Zhang, Weichao Hu, Yanhong Wang, Miao Zhang, Meng Zhu, Chao Wang, Yudong Wu, Jie Wang, Dongming Xing. The translational potential of miR-26 in atherosclerosis and development of agents for its target genes ACC1/2, COL1A1, CPT1A, FBP1, DGAT2, and SMAD7. Cardiovascular Diabetology 2024; 23(1) doi: 10.1186/s12933-024-02119-z
|
| 33 |
Yan Wang. The inhibition of microRNA-15a suppresses hepatitis B virus-associated liver cancer cell growth through the Smad/TGF-β pathway. Oncology Reports 2017; 37(6): 3520 doi: 10.3892/or.2017.5618
|
| 34 |
Jinghan Li, Simeng Wang, Jiaqi Duan, Peixin Le, Chao Li, Yongpei Ding, Rui Wang, Yonggang Gao. The protective mechanism of resveratrol against hepatic injury induced by iron overload in mice. Toxicology and Applied Pharmacology 2021; 424: 115596 doi: 10.1016/j.taap.2021.115596
|
| 35 |
Jessye Wojtusik, Erin Curry, Terri L. Roth. Rhinoceros Serum microRNAs: Identification, Characterization, and Evaluation of Potential Iron Overload Biomarkers. Frontiers in Veterinary Science 2021; 8 doi: 10.3389/fvets.2021.711576
|
| 36 |
Ayman Yosry, Naglaa Zayed, Reham M Dawood, Marwa K Ibrahim, Marwa Elsharkawy, Sherif M Ekladious, Ahmed Khairy, Aisha Elsharkawy, Marwa Khairy, Shereen Abdel Alem, Noha G Bader El Din, Mostafa K El Awady, Zeinab Abdellatif. Highly Sensitive Serum miRNA Panel for the Diagnosis of Hepatocellular Carcinoma in Egyptian Patients with HCV-Related HCC. Laboratory Medicine 2022; 53(5): 523 doi: 10.1093/labmed/lmac045
|
| 37 |
Jun Zhao, Matthew W. Lawless. Stop feeding cancer: Pro-inflammatory role of visceral adiposity in liver cancer. Cytokine 2013; 64(3): 626 doi: 10.1016/j.cyto.2013.09.009
|
| 38 |
Jun Zhao, Matthew W. Lawless. Long noncoding RNAs and their role in the liver cancer axis. Nature Reviews Gastroenterology & Hepatology 2013; 10(12): 703 doi: 10.1038/nrgastro.2013.87-c1
|
| 39 |
Anna Emilia Kern, Gregor Ortmayr, Alice Assinger, Patrick Starlinger. The role of microRNAs in the different phases of liver regeneration. Expert Review of Gastroenterology & Hepatology 2023; 17(10): 959 doi: 10.1080/17474124.2023.2267422
|
| 40 |
Jianxing Zheng, Daming Cheng, Dongyang Wu, Libing Wang, Fengzhi Qu, Xiaotang Wu, Ling Cheng, Yanbin Wei, Xiaogang Liu. MiR-452-5p Mediates the Proliferation, Migration and Invasion of Hepatocellular Carcinoma Cells Via Targeting COLEC10. Personalized Medicine 2021; 18(2): 97 doi: 10.2217/pme-2020-0027
|
| 41 |
Liang Liang, Jiang-hui Zeng, Jie-yu Wang, Rong-quan He, Jie Ma, Gang Chen, Xiao-yong Cai, Xiao-hua Hu. Down-regulation of miR-26a-5p in hepatocellular carcinoma: A qRT-PCR and bioinformatics study. Pathology - Research and Practice 2017; 213(12): 1494 doi: 10.1016/j.prp.2017.10.001
|
| 42 |
Juliane Liese, Jan Peveling-Oberhag, Claudia Doering, Andreas A. Schnitzbauer, Eva Herrmann, Stephan Zangos, Martin L. Hansmann, Christian Moench, Martin W. Welker, Stefan Zeuzem, Wolf O. Bechstein, Frank Ulrich. A possible role of microRNAs as predictive markers for the recurrence of hepatocellular carcinoma after liver transplantation. Transplant International 2016; 29(3): 369 doi: 10.1111/tri.12733
|
| 43 |
Jun Zhao, Catherine M Greene, Steven G Gray, Matthew W Lawless. Long noncoding RNAs in liver cancer: what we know in 2014. Expert Opinion on Therapeutic Targets 2014; 18(10): 1207 doi: 10.1517/14728222.2014.941285
|
| 44 |
Amar Mahgoub, Clifford Steer. MicroRNAs in the Evaluation and Potential Treatment of Liver Diseases. Journal of Clinical Medicine 2016; 5(5): 52 doi: 10.3390/jcm5050052
|
| 45 |
Hamzeh Karimkhanloo, Samira Mohammadi-Yeganeh, Razie Hadavi, Ameneh Koochaki, Mahdi Paryan. Potential role of miR-214 in β-catenin gene expression within hepatocellular carcinoma. Molecular Biology Reports 2020; 47(10): 7429 doi: 10.1007/s11033-020-05798-5
|
| 46 |
Reza Mahmoudi-Lamouki, Sepideh Kadkhoda, Bashdar Mahmud Hussen, Soudeh Ghafouri-Fard. Emerging role of miRNAs in the regulation of ferroptosis. Frontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1115996
|
| 47 |
Guang-Ping Qiu, Jie Liu. MicroRNA Gene Polymorphisms in Evaluating Therapeutic Efficacy After Transcatheter Arterial Chemoembolization for Primary Hepatocellular Carcinoma. Genetic Testing and Molecular Biomarkers 2016; 20(10): 579 doi: 10.1089/gtmb.2016.0073
|
| 48 |
Yang An, Song Gao, Wen-Chao Zhao, Bao-An Qiu, Nian-Xin Xia, Peng-Jun Zhang, Zhen-Ping Fan. Novel serum microRNAs panel on the diagnostic and prognostic implications of hepatocellular carcinoma. World Journal of Gastroenterology 2018; 24(24): 2596-2604 doi: 10.3748/wjg.v24.i24.2596
|